Zdrowie i gospodarka · 22/07/2024
FDA Seeks Public Comment on Proposed Diversity Action Plans for Clinical Studies
The Food and Drug Administration (FDA) is requesting public input on its proposed collection of information related to Diversity Action Plans for Clinical Studies, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →